Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Reinsurance Gr Analyst Ratings and Price Targets | NYSE:RGA | Benzinga
Reinsurance Group of America Inc has a consensus price target of $212.53 based on the ratings of 18 analysts. The high is $270 issued by Evercore ISI Group on March 13, 2025. The low is $64 issued by Jefferies on July 10, 2024. The 3 most-recent analyst ratings were released by Morgan Stanley, Wells Fargo, and JP Morgan on July 14, 2025, July 10, 2025, and July 8, 2025, respectively. With an average price target of $241 between Morgan Stanley, Wells Fargo, and JP Morgan, there's an implied 24.25% upside for Reinsurance Group of America Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Wells Fargo
JP Morgan
Keefe, Bruyette & Woods
UBS
1calculated from analyst ratings
Analyst Ratings for Reinsurance Gr
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
07/14/2025 | 8.27% | Morgan Stanley | $209 → $210 | Maintains | Equal-Weight | |||
07/10/2025 | 28.38% | Wells Fargo | $248 → $249 | Maintains | Overweight | |||
07/08/2025 | 36.11% | JP Morgan | $237 → $264 | Maintains | Overweight | |||
05/23/2025 | — | Raymond James | — | Downgrade | Strong Buy → Market Perform | |||
05/19/2025 | 7.75% | Morgan Stanley | $195 → $209 | Maintains | Equal-Weight | |||
05/07/2025 | 31.47% | Keefe, Bruyette & Woods | $250 → $255 | Maintains | Outperform | |||
05/06/2025 | 27.86% | Wells Fargo | $246 → $248 | Maintains | Overweight | |||
04/10/2025 | 26.83% | Wells Fargo | $264 → $246 | Maintains | Overweight | |||
04/09/2025 | 28.89% | Keefe, Bruyette & Woods | $275 → $250 | Maintains | Outperform | |||
04/02/2025 | 11.36% | UBS | $250 → $216 | Downgrade | Buy → Neutral | |||
04/02/2025 | 22.19% | JP Morgan | $232 → $237 | Upgrade | Neutral → Overweight | |||
03/13/2025 | 39.2% | Evercore ISI Group | $280 → $270 | Maintains | Outperform | |||
02/25/2025 | 36.11% | Wells Fargo | $263 → $264 | Maintains | Overweight | |||
02/19/2025 | 35.59% | Wells Fargo | $244 → $263 | Maintains | Overweight | |||
02/14/2025 | 20.13% | Morgan Stanley | $245 → $233 | Maintains | Equal-Weight | |||
02/10/2025 | 26.31% | RBC Capital | $245 → $245 | Reiterates | Outperform → Outperform | |||
02/10/2025 | 24.77% | Piper Sandler | $252 → $242 | Maintains | Overweight | |||
01/07/2025 | 19.61% | JP Morgan | $227 → $232 | Maintains | Neutral | |||
01/06/2025 | 29.92% | Barclays | $255 → $252 | Maintains | Overweight | |||
11/22/2024 | 31.47% | Barclays | $250 → $255 | Maintains | Overweight | |||
11/04/2024 | 26.31% | RBC Capital | $235 → $245 | Maintains | Outperform | |||
10/10/2024 | 25.8% | Wells Fargo | $239 → $244 | Maintains | Overweight | |||
10/09/2024 | 21.16% | TD Cowen | → $235 | Initiates | → Hold | |||
10/08/2024 | 28.89% | Barclays | $255 → $250 | Maintains | Overweight | |||
10/03/2024 | 14.46% | JP Morgan | $220 → $222 | Maintains | Neutral | |||
10/02/2024 | 24.77% | Piper Sandler | $237 → $242 | Maintains | Overweight | |||
09/24/2024 | 28.89% | Raymond James | $228 → $250 | Maintains | Strong Buy | |||
09/04/2024 | 31.47% | Barclays | → $255 | Initiates | → Overweight | |||
08/19/2024 | 21.67% | Morgan Stanley | $238 → $236 | Maintains | Equal-Weight | |||
08/09/2024 | 23.22% | Wells Fargo | $236 → $239 | Maintains | Overweight | |||
08/05/2024 | 21.16% | RBC Capital | $225 → $235 | Maintains | Outperform | |||
08/02/2024 | 13.43% | JP Morgan | $208 → $220 | Maintains | Neutral | |||
07/23/2024 | 29.92% | Citigroup | $194 → $252 | Maintains | Buy | |||
07/10/2024 | -67% | Jefferies | $63 → $64 | Maintains | Buy | |||
07/10/2024 | 11.88% | Morgan Stanley | $216 → $217 | Maintains | Equal-Weight | |||
07/02/2024 | 7.24% | JP Morgan | $195 → $208 | Maintains | Neutral | |||
06/28/2024 | 27.35% | Jefferies | $240 → $247 | Maintains | Buy | |||
06/28/2024 | 21.16% | Piper Sandler | $228 → $235 | Maintains | Overweight | |||
06/26/2024 | 24.25% | Evercore ISI Group | $225 → $241 | Maintains | Outperform | |||
06/14/2024 | 17.55% | Raymond James | $212 → $228 | Maintains | Strong Buy | |||
06/14/2024 | 16% | RBC Capital | $225 → $225 | Reiterates | Outperform → Outperform | |||
05/30/2024 | 23.74% | UBS | $223 → $240 | Maintains | Buy | |||
05/10/2024 | 17.03% | Wells Fargo | $210 → $227 | Maintains | Overweight | |||
05/07/2024 | 21.16% | Keefe, Bruyette & Woods | $220 → $235 | Maintains | Outperform | |||
05/03/2024 | 0.54% | JP Morgan | $189 → $195 | Maintains | Neutral | |||
04/15/2024 | -4.62% | Morgan Stanley | $178 → $185 | Maintains | Equal-Weight | |||
04/12/2024 | 9.3% | RBC Capital | $212 → $212 | Reiterates | Outperform → Outperform | |||
04/11/2024 | 8.27% | Wells Fargo | $193 → $210 | Maintains | Overweight | |||
04/11/2024 | 10.85% | Evercore ISI Group | $200 → $215 | Maintains | Outperform | |||
04/10/2024 | 13.43% | Keefe, Bruyette & Woods | $200 → $220 | Maintains | Outperform | |||
04/10/2024 | 14.97% | UBS | $198 → $223 | Maintains | Buy | |||
04/05/2024 | 13.43% | Piper Sandler | $195 → $220 | Maintains | Overweight | |||
04/02/2024 | -2.56% | JP Morgan | $170 → $189 | Maintains | Neutral | |||
03/26/2024 | 3.11% | Keefe, Bruyette & Woods | $200 → $200 | Maintains | Outperform | |||
02/06/2024 | -0.49% | Wells Fargo | $186 → $193 | Maintains | Overweight | |||
02/05/2024 | 2.08% | UBS | $191 → $198 | Maintains | Buy | |||
02/05/2024 | -4.62% | RBC Capital | $170 → $185 | Maintains | Outperform | |||
01/10/2024 | -1.53% | UBS | $167 → $191 | Maintains | Buy | |||
12/11/2023 | -2.56% | Jefferies | $171 → $189 | Upgrade | Hold → Buy | |||
11/15/2023 | -12.35% | Morgan Stanley | $164 → $170 | Maintains | Equal-Weight | |||
11/03/2023 | -15.45% | Morgan Stanley | $162 → $164 | Maintains | Equal-Weight | |||
10/06/2023 | -12.35% | JP Morgan | $168 → $170 | Maintains | Neutral | |||
09/14/2023 | -18.02% | Jefferies | $160 → $159 | Maintains | Hold | |||
08/18/2023 | -16.48% | Morgan Stanley | $160 → $162 | Maintains | Equal-Weight | |||
08/15/2023 | -12.87% | Wells Fargo | $168 → $169 | Maintains | Overweight | |||
08/09/2023 | -16.48% | Citigroup | $170 → $162 | Maintains | Buy | |||
08/04/2023 | -17.51% | Morgan Stanley | $160 → $160 | Reiterates | Equal-Weight → Equal-Weight | |||
07/17/2023 | -13.38% | Wells Fargo | $169 → $168 | Maintains | Overweight | |||
06/23/2023 | -17.51% | Jefferies | $170 → $160 | Downgrade | Buy → Hold | |||
06/16/2023 | -14.42% | RBC Capital | → $166 | Reiterates | Outperform → Outperform | |||
06/07/2023 | 2.6% | Raymond James | → $199 | Initiates | → Strong Buy | |||
05/24/2023 | -21.63% | Credit Suisse | $144 → $152 | Maintains | Neutral | |||
05/23/2023 | -12.35% | Citigroup | $158 → $170 | Maintains | Buy | |||
05/15/2023 | -12.87% | Wells Fargo | $163 → $169 | Maintains | Overweight | |||
05/08/2023 | -14.42% | RBC Capital | $164 → $166 | Maintains | Outperform | |||
04/25/2023 | -15.96% | Wells Fargo | → $163 | Initiates | → Overweight | |||
04/20/2023 | -15.45% | RBC Capital | $170 → $164 | Maintains | Outperform | |||
04/20/2023 | -24.73% | Barclays | $141 → $146 | Maintains | Equal-Weight | |||
04/13/2023 | -12.35% | RBC Capital | → $170 | Reiterates | → Outperform | |||
04/12/2023 | -27.3% | Barclays | $148 → $141 | Maintains | Equal-Weight | |||
03/15/2023 | -18.54% | Citigroup | → $158 | Upgrade | Sell → Buy | |||
01/10/2023 | -17.51% | Morgan Stanley | $145 → $160 | Maintains | Equal-Weight | |||
01/09/2023 | -16.48% | Goldman Sachs | $147 → $162 | Maintains | Buy | |||
01/06/2023 | -27.3% | JP Morgan | $136 → $141 | Maintains | Neutral | |||
01/05/2023 | -13.9% | Evercore ISI Group | $148 → $167 | Upgrade | In-Line → Outperform | |||
12/06/2022 | -12.35% | RBC Capital | $145 → $170 | Upgrade | Sector Perform → Outperform | |||
11/08/2022 | -23.7% | Barclays | $138 → $148 | Maintains | Equal-Weight | |||
11/07/2022 | -25.24% | RBC Capital | $132 → $145 | Maintains | Sector Perform | |||
11/04/2022 | -25.24% | Morgan Stanley | $140 → $145 | Maintains | Equal-Weight | |||
10/31/2022 | -29.88% | JP Morgan | → $136 | Downgrade | Overweight → Neutral | |||
10/14/2022 | -28.85% | Barclays | $135 → $138 | Maintains | Equal-Weight | |||
08/17/2022 | -27.82% | Morgan Stanley | $135 → $140 | Maintains | Equal-Weight | |||
08/16/2022 | -30.4% | Barclays | $120 → $135 | Maintains | Equal-Weight | |||
08/08/2022 | -30.4% | Morgan Stanley | $131 → $135 | Maintains | Equal-Weight | |||
08/08/2022 | -31.94% | RBC Capital | $130 → $132 | Maintains | Sector Perform | |||
08/03/2022 | -38.13% | Barclays | → $120 | Initiates | → Equal-Weight |
FAQ
What is the target price for Reinsurance Gr (RGA) stock?
The latest price target for Reinsurance Gr (NYSE:RGA) was reported by Morgan Stanley on July 14, 2025. The analyst firm set a price target for $210.00 expecting RGA to rise to within 12 months (a possible 8.27% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Reinsurance Gr (RGA)?
The latest analyst rating for Reinsurance Gr (NYSE:RGA) was provided by Morgan Stanley, and Reinsurance Gr maintained their equal-weight rating.
When was the last upgrade for Reinsurance Gr (RGA)?
The last upgrade for Reinsurance Group of America Inc happened on April 2, 2025 when JP Morgan raised their price target to $237. JP Morgan previously had a neutral for Reinsurance Group of America Inc.
When was the last downgrade for Reinsurance Gr (RGA)?
The last downgrade for Reinsurance Group of America Inc happened on May 23, 2025 when Raymond James changed their price target from N/A to N/A for Reinsurance Group of America Inc.
When is the next analyst rating going to be posted or updated for Reinsurance Gr (RGA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Reinsurance Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Reinsurance Gr was filed on July 14, 2025 so you should expect the next rating to be made available sometime around July 14, 2026.
Is the Analyst Rating Reinsurance Gr (RGA) correct?
While ratings are subjective and will change, the latest Reinsurance Gr (RGA) rating was a maintained with a price target of $209.00 to $210.00. The current price Reinsurance Gr (RGA) is trading at is $193.96, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
